Photo by nci from unsplash
Eccrine porocarcinoma (EPC) is a rare, malignant tumour of the eccrine sweat glands. It was first described as "epidermotropic eccrine carcinoma" in 1963 by Pinkus and Mehregan. EPC represents 0.005%… Click to show full abstract
Eccrine porocarcinoma (EPC) is a rare, malignant tumour of the eccrine sweat glands. It was first described as "epidermotropic eccrine carcinoma" in 1963 by Pinkus and Mehregan. EPC represents 0.005% to 0.01% of cutaneous tumours, but it is one of the most common malignant cutaneous adnexal tumours.2 Studies have been limited due to its rarity, and controversies regarding tumour behaviour and treatment are present in the literature. Previous studies have been limited to case reports, case series, literature reviews, and meta-analyses. We aim to investigate the association of patient demographics, tumour stage, and treatment modalities with overall survival (OS) in patients with EPC using the National Cancer Database (NCDB) from 2004-2016.
Journal Title: British Journal of Dermatology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!